NR4A1 and invasive breast carcinoma: After an average of 10 years of treatment and follow-up, low-dose aspirin (100 mg every other day) had no effect on risk of invasive breast cancer overall or by combined hormone receptor status in 39 876 women aged ⩾45 years.